Abstract

Chronic (neuropathic) pain is one of the most widespread and intractable of human complaints, as well as being one of the most difficult syndromes to treat successfully with drugs or surgery. The development of new therapeutic approaches to the treatment of painful neuropathies requires a better understanding of the mechanisms that underlie the development of these chronic pain syndromes. It is clear that inflammatory responses often accompany the development of neuropathic pain, and here we discuss the idea that chemokines might be key to integrating the development of pain and inflammation and could furnish new leads in the search for effective analgesic agents for the treatment of painful neuropathies.

Author affiliations

1. Department of Cell Biology, Neurobiology and Anatomy, and Department of Anesthesiology, Stritch School of Medicine, Loyola University, Maywood, Illinois 60153, USA.
2. Department of Molecular Pharmacology and Structural Biochemistry, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611, USA.

Correspondence to: Richard J. Miller² Email: r-miller10@northwestern.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.